High-dose aprotinin: hemostatic effects in open heart operations.

The Annals of Thoracic Surgery
F AlajmoA Palminiello

Abstract

Two groups of patients were prospectively studied to evaluate the hemostatic effects of high-dose aprotinin in open heart operations. Group A patients (n = 22) received aprotinin during the entire surgical procedure. Group B patients (n = 12) served as controls. The groups were homogeneous for base variables and for cardiopulmonary bypass duration. Postoperative bleeding was lower in group A (mean, 486 mL) than in group B (830 mL) (p less than 0.01). The need for banked blood decreased by approximately half in the aprotinin patients (mean: group A, 213 mL; group B, 409 mL). Hemoglobin levels were similar in the two groups (postoperative day 7: group A, 11.29 g/100 mL; group B, 11.26 g/100 mL; NS). Platelet count decreased at the end of operation in both groups (99,000 and 95,000/mL, respectively; NS) and then increased beyond baseline levels before discharge. No complications were observed that could be attributed to aprotinin. In conclusion, we believe that the use of high-dose aprotinin is safe and effective. It decreases blood loss and reduces the need for banked blood in cardiac operations, particularly in select groups of patients (eg, those undergoing reoperation, Jehovah's Witnesses, those with renal failure).

References

Dec 1, 1987·The Annals of Thoracic Surgery·W van OeverenC R Wildevuur
Dec 1, 1983·The Journal of Thoracic and Cardiovascular Surgery·J K KirklinA D Pacifico
May 1, 1981·The Annals of Thoracic Surgery·J R UtleyD B Stephens

❮ Previous
Next ❯

Citations

Jan 1, 1997·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·G ChengX Du
Jul 4, 2001·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Y UozakiT Misaki
Apr 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J F Hardy, J Desroches
Nov 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J F Hardy, S Bélisle
Mar 1, 1995·The Annals of Thoracic Surgery·J A RousouS G Owen
Jun 1, 1996·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·M ChikadaK Yagyu
Nov 1, 1992·The Annals of Thoracic Surgery·F Alajmo, G Calamai
Feb 1, 1992·Journal of Cardiothoracic and Vascular Anesthesia·D Royston
Jun 1, 1992·Journal of Cardiothoracic and Vascular Anesthesia·W DietrichJ A Richter
Jun 1, 1991·The Journal of Thoracic and Cardiovascular Surgery·B BlauhutP Lundsgaard-Hansen
Dec 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·D Royston
Dec 1, 1990·The Annals of Thoracic Surgery·E SantoliC Santoli
Dec 1, 1990·The Annals of Thoracic Surgery·G M GuiraudonD M Cade
Dec 1, 1992·The Annals of Thoracic Surgery·D M CosgroveF D Loop
May 1, 1993·The Annals of Thoracic Surgery·M KawasujiY Watanabe
May 1, 1990·The Annals of Thoracic Surgery·R W Frater
Dec 1, 1994·The Annals of Thoracic Surgery·S E FremesC D Naylor
Apr 1, 1993·The Annals of Thoracic Surgery·S Westaby
Mar 1, 1993·The Annals of Thoracic Surgery·H TatarH Işiklar
Mar 1, 1993·The Annals of Thoracic Surgery·D M NajmanR Pifarré
Apr 10, 2007·Journal of Cardiothoracic and Vascular Anesthesia·John G T Augoustides
Sep 1, 1999·Journal of Cardiothoracic and Vascular Anesthesia·M BasoraA Ordinas
Sep 15, 1993·Thrombosis Research·J M HerbertJ P Maffrand
Feb 1, 1995·Anesthesiology·J C HorrowJ L Parmet
Aug 1, 1997·The British Journal of Surgery·C J RanaboldoA D Chant
Mar 16, 2001·Expert Opinion on Pharmacotherapy·P P PunjabiK M Taylor
Sep 28, 2007·Anesthesia and Analgesia·Matthew D McEvoyFrancis G Spinale
Apr 1, 1996·The Annals of Pharmacotherapy·S RobertM Richer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.